Hudson Valley Urology

Poughkeepsie, New York 12601

0 studies enrolling now · 12 studies all time

What they study most

Benign Prostatic Hypertrophy, Bladder Cancer, Bladder Cancer Recurrence, Bladder Neoplasms, Microscopic or Gross Hematuria, Overactive Bladder, Overactive Bladder Syndrome (OABS), Primary Prevention of Atherosclerotic Cardiovascular Disease, Prostate Cancer, Prostatic Neoplasms, Urinary Incontinence

Studies at this site

• A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients. — Running, not enrolling
• Single Dose Intravesical Apaziquone Postoperative in Patients Undergoing TURBT for Noninvasive Bladder Cancer (SPI-611) — Completed
• Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH) — Stopped early
• Mycobacterial Cell Wall-DNA Complex in Treatment of BCG-refractory Patients With Non-muscle Invasive Bladder Cancer — Completed
• SMP-986 Phase 2 Proof of Concept in Patients With Overactive Bladder Syndrome (OABS) — Completed
• MILADY: A Randomized, Placebo-controlled Safety and Efficacy Trial of SSR240600C in Treatment of Overactive Bladder or Urge Urinary Incontinence. — Completed
• Observational Study of Subjects Having Routine Recurrence Screening for Bladder Cancer — Completed
• Hematuria Evaluation Trial for Subjects With Microscopic or Gross Hematuria to Determine the Absence or Presence of Bladder Cancer — Completed
• Efficacy and Safety Study of a New Leuprolide Acetate 17 mg Depot to Treat Prostate Cancer Patients — Stopped early
• Study of a 6-Month Sustained-Release Formulation of Leuprolide Acetate in Prostate Cancer — Completed
• Using Behavioral Therapy in Combination With Darifenacin for Symptoms of Overactive Bladder — Completed
• Leuprolide Acetate 3.75 mg Depot to Treat Prostate Cancer — Completed